Oracle Just Delivered a Record-Breaking Quarter, Complete with a Beat and Raise. So Why Is the Stock Falling?

Oracle posted record fiscal Q4 revenue of $19.2B, up 21% year over year, with adjusted EPS of $2.11 versus $1.96 expected, and cloud revenue rose 47% to $9.9B. The company’s RPO surged to a record $638B, including large AI-related contracts, and it raised fiscal 2027 EPS guidance to $8.05 while keeping revenue guidance at $90B. Shares fell as much as 10% after hours on concerns about a planned $40B capital raise, possible dilution, and cloud revenue narrowly missing estimates.

Analysis

The market is treating Oracle less like a software compounder and more like a leveraged infrastructure vendor with a funding problem. That re-rating matters: when a hyperscaler-style buildout becomes equity-and-debt financed, the stock starts trading on capital intensity, not just revenue growth, and the multiple can compress even when bookings accelerate. The hidden beneficiary is actually the GPU ecosystem and adjacent data-center supply chain, because Oracle’s willingness to preload capex via customer-funded contracts lowers near-term execution risk and shifts demand visibility out the curve.

The key second-order risk is not the quarter itself; it is balance-sheet elasticity over the next 4-8 quarters. If the company leans on debt while already carrying a large absolute debt load, incremental funding costs can rise faster than operating leverage, especially if cloud margins remain noisy during capacity ramp. That creates a setup where the stock can underperform on good fundamentals until investors see proof that backlog converts into cash flow rather than just future capex commitments.

Consensus appears too focused on the modest revenue miss and not focused enough on the financing structure embedded in the AI opportunity. If Oracle can keep converting pre-funded AI demand into shipped capacity, the market is underestimating the optionality in long-dated earnings power; if not, the current backlog becomes a source of disappointment because it inflates expectations without immediate free cash flow. The move is likely overdone tactically, but not obviously wrong strategically — that distinction favors trading the volatility rather than blindly buying the dip.

Key Decisions for Investors

• Short-term: buy ORCL 1-2 month at-the-money calls only on an additional 5-8% drawdown; risk/reward improves if the market is pricing financing fear rather than demand deterioration.
• Relative value: long MSFT / short ORCL over the next 3-6 months as a hedge against AI infrastructure skepticism; MSFT has cleaner balance-sheet flexibility and less dilution sensitivity.
• Event-driven: sell ORCL cash-secured puts 10-15% below spot with 6-10 week tenor if implied volatility stays elevated; monetize the overreaction while defining downside.
• Monitor NVDA for secondary benefit over 1-2 quarters: Oracle’s customer-funded GPU demand supports order flow visibility, but any pullback in ORCL capex plans would be a negative read-through for near-term AI hardware sentiment.